GetTopicDetailResponse(id=c0081e411b, topicName=Abemaciclib, introduction=Abemaciclib, content=null, image=null, comments=1, allHits=1761, url=https://h5.medsci.cn/topic?id=1741, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=35427, tagList=[TagDto(tagId=35427, tagName=Abemaciclib)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=895910, encodeId=f31f895910f3, content=HR+HER2-晚期<a href='/topic/show?id=73c423e2572' target=_blank style='color:#2F92EE;'>#乳腺癌#</a>的<a href='/topic/show?id=635c8513167' target=_blank style='color:#2F92EE;'>#腦轉(zhuǎn)移#</a>可以優(yōu)先<a href='/topic/show?id=c0081e411b' target=_blank style='color:#2F92EE;'>#Abemaciclib#</a>治療, objectTitle=Clin Cancer Res：HR+HER2-腦轉(zhuǎn)移乳腺癌患者從Abemaciclib治療中獲益最大, objectType=article, longId=202711, objectId=dfca202e11b8, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20201031/1604128010953_2467676.JPG, objectUrl=/article/show_article.do?id=dfca202e11b8, replyNumber=0, likeNumber=232, createdTime=2020-10-31, rootId=0, userName=lovetcm, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dfca202e11b8, moduleTitle=Clin Cancer Res：HR+HER2-腦轉(zhuǎn)移乳腺癌患者從Abemaciclib治療中獲益最大, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=dfca202e11b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
